Filtered By:
Management: Marketing
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 200 results found since Jan 2013.
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
ATLANTA, Dec. 18, 2019 -- (Healthcare Sales & Marketing Network) -- NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, today announced the appointment of Todd Verdoorn, PhD., as Vice President of Research and Development. In this capacity, Dr. ... Biopharmaceuticals, Neurology, Personnel NeuroTrauma Sciences, stroke, traumatic brain injury
Source: HSMN NewsFeed - December 18, 2019 Category: Pharmaceuticals Source Type: news
Sodium –Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
In 2008, the European Medicines Agency and US Food and Drug Administration (FDA) issued industry guidance stating that all future novel glucose-lowering agent trials must undergo routine cardiovascular risk evaluation either before approval or as a post-marketing commitment.1 This mandated that all cardiovascular endpoint committees prospectively adjudicate all major adverse cardiovascular events, including cardiovascular death, non-fatal MI and stroke, occurring across Phase II and III diabetes trials.
Source: Radcliffe Cardiology - November 4, 2019 Category: Cardiology Authors: mehul Source Type: research
12 Innovations That Will Change Health Care and Medicine in the 2020s
Pocket-size ultrasound devices that cost 50 times less than the machines in hospitals (and connect to your phone). Virtual reality that speeds healing in rehab. Artificial intelligence that’s better than medical experts at spotting lung tumors. These are just some of the innovations now transforming medicine at a remarkable pace.
No one can predict the future, but it can at least be glimpsed in the dozen inventions and concepts below. Like the people behind them, they stand at the vanguard of health care. Neither exhaustive nor exclusive, the list is, rather, representative of the recasting of public health and medic...
Source: TIME: Health - October 25, 2019 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized HealthSummit19 technology Source Type: news
FDA Clears GEKO DEVICE for Use in Non-surgical Patients at Risk for Deep Vein Thrombosis Based on Study Demonstrating a Zero Percent DVT Rate in Patients After a Stroke
Sky Medical Technology furthers presence in 3.5bn1 dollar US market for VTE prevention
DARESBURY, England, Oct. 10, 2019 -- (Healthcare Sales & Marketing Network) -- UK-based medical devices company, Sky Medical Technology Ltd, has received U.S. Food a... Devices, FDA Sky Medical Technology, geko, Deep Vein Thrombosis, venous thromboembolism
Source: HSMN NewsFeed - October 10, 2019 Category: Pharmaceuticals Source Type: news
How the Vaping Industry Is Using a Defensive Tactic Pioneered Decades Ago by Big Tobacco
Each week brings a new story of some calamity brought by vaping.
In late July, a Connecticut man filed suit against e-cigarette giant Juul Labs after suffering a massive stroke. The suit alleges that he became addicted while he was still a high schooler, even though the company says it is specifically taking action to prevent young people from trying the product. In August, an Illinois patient died after vaping, succumbing to a mysterious respiratory illness; news broke teens in the Midwest hospitalized with severe and unexplained respiratory symptoms; and the FDA announced that that it was investigating the relationship b...
Source: TIME: Health - October 2, 2019 Category: Consumer Health News Authors: Sarah Milov Tags: Uncategorized health Opinion politics Source Type: news
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
AUSTIN, Texas, Aug. 28, 2019 -- (Healthcare Sales & Marketing Network) -- Harmonic Bionics, Inc. announced today that Christopher Prentice has been appointed Chief Executive Officer and member of the Harmonic Bionics Board of Directors effective immediate... Devices, Personnel Harmonic Bionics, stroke, spinal cord injury, neurorehabilitation
Source: HSMN NewsFeed - August 28, 2019 Category: Pharmaceuticals Source Type: news
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
ENGLEWOOD, Colo., July 22, 2019 -- (Healthcare Sales & Marketing Network) -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabili... Devices, Personnel Zynex, NeuroMove
Source: HSMN NewsFeed - July 22, 2019 Category: Pharmaceuticals Source Type: news
What is the impact of user affect on motor learning in virtual environments after stroke? A scoping review
The purported affective impact of virtual reality (VR) and active video gaming (AVG) systems is a key marketing strategy underlying their use in stroke rehabilitation, yet little is known as to how affective c...
Source: Journal of NeuroEngineering and Rehabilitation - June 27, 2019 Category: Rehabilitation Authors: Nina Rohrbach, Emily Chicklis and Danielle Elaine Levac Tags: Review Source Type: research
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
Advent of the Soft Exo-Suit Generation expands assistive robotic therapy for stroke survivors
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 -- (Healthcare Sales & Marketing Network) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk"... Devices, Regulatory ReWalk Robotics, exo-suit, stroke
Source: HSMN NewsFeed - May 29, 2019 Category: Pharmaceuticals Source Type: news
ReNeuron Provides Business Update and Results Notification
Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete
LONDON, May 8, 2019 -- (Healthcare Sales & Marketing Network) -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced a year-end... Regenerative Medicine, Ophthalmology, Neurology ReNeuron Group, retinitis pigmentosa, stroke, stem cell
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news
More Research Is Needed on Lifestyle Behaviors That Influence Progression of Parkinson's Disease
This article highlights some of these challenges in the design of lifestyle studies in PD, and suggests a more coordinated international effort is required, including ongoing longitudinal observational studies. In combination with pharmaceutical treatments, healthy lifestyle behaviors may slow the progression of PD, empower patients, and reduce disease burden. For optimal care of people with PD, it is important to close this gap in current knowledge and discover whether such associations exist.
Introduction
Parkinson's disease (PD) is an age-related complex progressive neurodegenerative disorder, with key p...
Source: Frontiers in Neurology - April 29, 2019 Category: Neurology Source Type: research
In Brief: Tegaserod (Zelnorm) Returns
Date: May 6, 2019
Issue #:
1571Summary:
Tegaserod maleate(Zelnorm), a 5-HT4 receptor partial agonist that increases gastrointestinal (GI) motility, was approved by the FDA in 2002 for short-term treatment of irritable bowel syndrome with constipation (IBS-C) in women and in 2004 for treatment of chronic idiopathic constipation (CIC) in adults<65 years old.In 2007, the manufacturer (Novartis) complied with an FDA request to stop marketing the drug based on an unpublished retrospective analysis of clinical trials in IBS-C and other GI motility disorders that showed a higher rate of ischemic ...
Source: The Medical Letter - April 26, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Constipation irritable bowel syndrome Motegrity prucalopride Resotran Tegaserod Zelnorm Source Type: research
Financing Paves Way for Rapid to Enter the U.S. Market
Rapid Medical said it has raised $20 million in a series C round to give its IDE trial a boost. The Yokneam, Israel-based company is developing minimally invasive stroke treatment and protection products.
Rapid has been successfully enrolling patients in the TIGER IDE study in the U.S. since May of 2018.
In addition, the proceeds will be used to develop a commercial presence in the U.S. ahead of regulatory approvals, expanding the company's sales and marketing efforts in Europe, as well as the development of additional innovative products.
The financing round was led by JAM Capital Partners and MicroPort with participation...
Source: MDDI - April 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news
Learning to Walk Again
When someone suffers a stroke, he or she often loses some mobility, and some 60 percent of survivors are left with lower-limb deficits. “They usually have one leg that's more impaired than the other leg, and then they undergo rehabilitation and physical therapy. And often they don't fully recover,†said Conor Walsh, professor of engineering and applied sciences at the John A. Paulson Harvard School of Engineering and Applied Sciences and a core faculty member at the Wyss Institute for Biologically Inspired Engineering, in an interview with MD+DI.
But a new device called ReSto...
Source: MDDI - April 17, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Design Source Type: news
